No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SDGR241220C17500
- 1.75
- -2.90-62.37%
15min DelayClose Dec 20 15:59 ET
2.00High1.75Low
2.00Open4.65Pre Close15 Volume70 Open Interest17.50Strike Price2.88KTurnover0.00%IV-0.98%PremiumDec 20, 2024Expiry Date1.94Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8.19Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
AI Driven Drug Discovery Patent Landscape Report 2024: 1,087 Patents Analyzed With Market Sales Data and Growth Rates - ResearchAndMarkets.com
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Express News | Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Schrodinger Inc: Received an Additional $9.5 Mln From Bill & Melinda Gates Foundation